Andrew B. Katims, MD

Dr. Andrew Katims is an attending physician with a sub-specialty in urologic oncology. He clinically treats all urologic malignancies and is an expert in bladder, prostate, kidney, and testis cancer. He has completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center and residency in urology at Icahn School of Medicine at Mount Sinai.

Prior to that, he earned his medical degree and master's in public health from University of Miami.

• His research is focused on urothelial cancer and ranges from understanding the tumor microenvironment and therapeutically altering the immune system to develop novel treatments to developing clinical models that aim to improve quality of life outcomes for patients with bladder cancer. These efforts have led to multiple peer-reviewed publications and awards, including the ASCO Young Investigator Award and recognition from both the American Urological Association as an early career investigator and the Bladder Cancer Advocacy Network as an up-and-coming bladder cancer researcher. Ultimately, Dr. Katims aims to improve diagnostic and therapeutic options for all patients, particularly those who are underserved with limited access to tertiary medical centers.